Clin2
NCT07609927Possibly a fitNot yet recruiting

Study of the enVVe Vein Valve System for Deep Vein Reflux

Chronic Venous Insufficiency, CVI

Part of Brain & nervous system, Eyes & vision clinical trials.

This trial tests an investigational device called the enVVe System to treat leg symptoms caused by damaged vein valves deep in the leg. If you have persistent leg pain, swelling, or skin changes despite using compression stockings, this study might help you. The device is placed into the vein to improve blood flow back to the heart.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
220 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have leg symptoms (like pain, swelling, or skin changes) that have not improved after at least 3 months of standard care (such as compression stockings or wound care)
  • Tests show your deep leg veins have faulty valves that let blood flow backward (reflux), usually lasting more than 1 second on an ultrasound
  • Your vein size is between 7.5 and 11.5 millimeters in the area to be treated, and your popliteal vein (behind the knee) is at least 4.7 millimeters wide
  • You can stand for an ultrasound and walk normally without help
  • Your body mass index (BMI) is under 40
  • You are willing to follow the study's follow-up schedule and take blood thinners as required
  • You do not have certain health conditions like active cancer, a recent blood clot, or a bleeding disorder
  • You are not pregnant or breastfeeding, and agree to use birth control if you could become pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07777978Recruiting
Home exercise and education for chronic venous insufficiency

This study tests a structured home-based exercise and education program for people with chronic venous insufficiency – a condition where veins in the legs have trouble sending blood back to the heart. If you qualify, you would do the program for 12 weeks to see if it helps improve your symptoms.

Bolu, Bolu
NCT07529756Not yet recruiting
Treating blocked leg veins with the ReCana catheter

This trial is testing a device called ReCana that removes blood clots from veins in the leg or pelvis. It aims to help people whose veins are blocked or narrowed, either for the first time or because a previous stent has become blocked again.

NCT04253301Recruiting
Testing a vein valve device for chronic venous valve leak

This study tests whether an implanted “vein valve” system can improve blood flow in people with painful chronic venous valve leakage in the thigh/knee veins. It also checks if the procedure and follow-up are safe and workable, especially with blood-thinner medicines before and after.

Nedlands, Western Australia
NCT07219758Recruiting
Recana device study for leg vein blockages

This trial tests a new device called the Recana Thrombectomy Catheter to clear blockages in the large veins of the legs or pelvis. It might help people with chronic leg swelling, pain, or open sores caused by poor blood flow out of the leg.

London
NCT06318988Not yet recruiting
Comparing treatments for chronic vein problems

This study compares different treatments for chronic venous disease (a condition where leg veins don't work properly, causing pain, swelling, and varicose veins). It aims to see which treatments work best, so you might get access to a range of options under careful medical supervision.

NCT05663359Recruiting
Compare two laser treatments for varicose vein reflux

This trial tests whether a 1940 nm or a 1470 nm laser works better for treating varicose veins in the legs. It may help you find a more effective option to reduce vein problems like swelling, heaviness, and visible bulges.

Toulouse

Hear when a new Chronic Venous Insufficiency, CVI trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.